Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 41 % of short-term debt in 2025; threshold 65 %.
-
Shrinking team NBB
FTE fell two years in a row, from 0.9 to 0.
Financials
Financial year 2025
Apotheek Muide from Gent, company number BE0883798870, closed financial year 2025 with a result of € -18,470 after tax. For that financial year Apotheek Muide recorded a gross margin of € 88,816 and equity of € 292,433. Compared with financial year 2024, the result moved from € -7,406 to € -18,470. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 5, 2026.
€ 292,433
▼ 6% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -18,470
▼ 149 % more loss than in 2024
Profit after tax over the fiscal year.
€ 8,467
▼ 56% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 261,433.
People and assets in 2025
0
▼ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 468
▼ 78% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 8,214
▼ 64% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 159,048
▼ 43% vs 2024
€ 62,966 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 279,458
▲ 3% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 2,044
▼ 40% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 40,455 | € 79,123 | € 108,965 | € 88,816 | ▼ 18% |
| Profit after taxes | € 779 | € 6,370 | € -7,406 | € -18,470 | ▼ € 11,064 |
| Equity | € 311,939 | € 318,309 | € 310,903 | € 292,433 | ▼ 6% |
| Total debts | € 377,631 | € 1,325,881 | € 1,178,376 | € 1,114,621 | ▼ 5% |
| Cash | € 32,043 | € 114,423 | € 19,367 | € 8,467 | ▼ 56% |
| Land & buildings | € 16,108 | € 13,165 | € 10,221 | € 7,278 | ▼ 29% |
| Retained profit | € 280,939 | € 287,309 | € 279,903 | € 261,433 | ▼ 7% |
| Bank debt | € 48,100 | € 422,528 | € 280,492 | € 159,048 | ▼ 43% |
| Balance sheet total | € 689,570 | € 1,644,190 | € 1,489,279 | € 1,407,054 | ▼ 6% |
| Employees (FTE) | 0.9 | 0.9 | 0.2 | 0 | ▼ 0.2 |
Key figures of Apotheek Muide, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek Muide?
What happened at Apotheek Muide in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 18,470. Source: NBB ↗
- Frapeja Invest BV became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 779 profit in 2022 to € 18,470 loss in 2025.
Paid € 3,878 in corporate taxes since 2022.
Best year ever: 2023, with € 6,370 profit.
A new publication or filing at Apotheek Muide? We notify you, reason included.
Follow Apotheek MuideDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Apotheek Muide is Frapeja Invest BV. Frapeja Invest BV is also behind FRAPEJA PHARMA and PHARTRIM.
Directors
According to the 2025 annual accounts
Director · represented by Steven Van Gansbeke
Also active at: FRAPEJA PHARMA, PHARTRIM
since 2024
Establishments
Establishment units
Physical locations of this company
Meulesteedsesteenweg 7
9000 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0883.798.870
- VAT number
- BE 0883.798.870
- Registered office
- Meulesteedsesteenweg 7, 9000 Gent
- Names & denominations
- Apotheek Muide
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 September 2006
- Peppol
- Active · Active since 12 Aug 2025
- Contact
- [email protected]
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers